In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

The Year in Diabetes and Obesity (2)

Edited by Edited by Rexford S. Ahima (University of Pennsylvania) and Alvin C. Powers (Vanderbilt University)
The Year in Diabetes and Obesity (2)

Published: December 2011

Volume 1243

Learn More

This second installment of The Year in Diabetes and Obesity review series includes thought-provoking reviews on central nervous system control of glucose and energy metabolism; stearoyl CoA desaturase in obesity and metabolism; circadian disruption and metabolic dysfunction; incretin hormones; metabolic syndrome, adipokines, and dementia; interventions for the prevention or reversal of type 1 diabetes; the role of intestinal microbiome in humans and mice with type 1 diabetes; building smarter and better insulins; RAGE––a multi-ligand receptor in chronic diseases; diabetes, cancer risk, and metformin––connections of metabolism and cell proliferation; prevalence of diabetes in Asia; and prioritization of care in adults with diabetes and co-existing chronic conditions.